Endovia Health Sciences closes initial funding to advance CannEpil development

Endovia Health Sciences says it has closed an initial funding tranche to accelerate CannEpil® development and commercialization, citing increased FDA and Congressional focus on regulated development and incentives for botanical, plant-derived medicines.